Johnson Marvin — SEC Form 4 filings
SEC reporting owner CIK 1852752. 5 Form 4 filings on record with FilingPulse; latest filed 2025-02-11.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-01-19 to 2025-02-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,610 shares, $869 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 1,610 shares @ $0.54 ($869) in MARINUS PHARMACEUTICALS, INC., filed 2025-01-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) | Director | 4 | — | 1 leg · 1,610 sh · $869 | 9 |
| TREVENA INC (TRVN) | Director | 1 | — | — | 1 |
Form 4 filings — Johnson Marvin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-11 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Disposition to issuer (D): 5,389 @ $0.55 · Disposition to issuer (D): 7,101 @ $0.55 · Disposition to issuer (D): 10,450 (derivative) @ $0 · Disposition to issuer (D): 20,900 (derivative) @ $0 · Disposition to issuer (D): 32,400 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale (S): 1,610 @ $0.54 | EDGAR |
| 2024-06-20 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 2,300 @ $0 · Grant/award (A): 10,450 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | TREVENA INC (TRVN) | Grant/award (A): 13,700 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 4,600 @ $0 · Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1852752 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →